CAS PROTEIN, CORRESPONDING GENE EDITING SYSTEM THEREOF AND USE THEREOF
Publication
EP4711451A1
Kind: A1
Mar 18, 2026
Applicants
Yoltech Therapeutics Co., Ltd
Inventors
ZHANG, Hongling
Abstract
The present disclosure provides a Cas protein, a composition comprising the Cas protein, and a CRISPR-Cas system. The present disclosure further provides applications and methods using the composition or the CRISPR-Cas system. The present disclosure further provides a cell comprising the Cas protein, the composition or the CRISPR-Cas system.
IPC Classifications
C12N 9/22 20060101AFI20241115BHEP
C12N 15/55 20060101ALI20241115BHEP
C12N 15/62 20060101ALI20241115BHEP
C12N 15/113 20100101ALI20241115BHEP
C12N 15/85 20060101ALI20241115BHEP
C07K 19/00 20060101ALI20241115BHEP
C12Q 1/6816 20180101ALI20241115BHEP
A61K 48/00 20060101ALI20241115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR